Hudson Bay Capital Management LP Moon Lake Immunotherapeutics Transaction History

Hudson Bay Capital Management LP

  • $21.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$38.43 - $48.6 $576,450 - $729,000
15,000 New
15,000 $659,000
Q4 2023

Feb 14, 2024
BUY
$36.35 - $63.02 $545,250 - $945,300
15,000 New
15,000 $905,000
Q2 2023

Aug 14, 2023
BUY
$19.01 - $51.79 $1.14 Million - $3.11 Million
60,000 New
60,000 $3.06 Million

Others Institutions Holding MLTX

# of Institutions
124
Shares Held
58.2M
Call Options Held
52.2K
Put Options Held
38K
View Full List

About MoonLake Immunotherapeutics

MLTX Quotes by TradingView
  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $2.14B
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email